Round Up: The Children's Blood and Cancer Center at Dell Children's Hospital
Here on one convenient page are links to my entries thus far on the Children's Blood and Cancer Center at Dell Children's Hospital in Austin for the Lymphoma Information Network, along with additional photo stream links.
Just click on the image to be taken to the article.
Introduction
Part I
- Additional photos: Prom pictures from the CBCC's Flickr stream and from my Smugmug gallery.
Part II
Part III
- Additional photos: The August 14 2013 Food Fight for Life from the CBCC's Flickr stream.
Part IV
- Additional photos: From the CBCC's Flickr stream and from my Smugmug gallery.
Future Installments
During the month of September I'll be joining the CBCC for their Survivorship Challenge Training, which is the CBCC's 8-week running program for patients ages 7-18 and their families who are seen in the CBCC or in the Survivorship clinic. The program helps to reintroduce being active to the kids and their families, and it concludes with a 5k.
I will also be profiling a couple of very unique adult survivors of childhood leukemia.
Thank you for swinging by and stay tuned!
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
